Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY conjugate vaccine in healthy adults
NCT00196950Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2003
- Primary completion
- Oct 2003
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Meningococcal polysaccharide (serogroups A, C, W, and Y) tetanus toxoid conjugate vaccine in invasive meningococcal disease (IMD), sponsored by GSK. Started Sep 2003; status: completed.
02
Drugs
Meningococcal polysaccharide (serogroups A, C, W, and Y) tetanus toxoid conjugate vaccine
03
Conditions
invasive meningococcal disease (IMD)
Beyond the preview
Go deeper on NCT00196950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00196950.